Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02632071
Title Phase I of ACY-1215 + Nab-paclitaxel in Breast Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Kevin Kalinsky

breast adenocarcinoma


Nab-paclitaxel + Ricolinostat

Age Groups: adult
Covered Countries USA

No variant requirements are available.